PillTalk

PillTalk PillTalk provides an EASY & SIMPLE approach to patient medication counseling! Check it out at http://bit.ly/PTstore Think there is something we are missing?

We’ve created an easy-to-use “cheat sheet” where you pick and choose from simplified counseling points! The goal is to be both patient and provider-friendly so that you can counsel your patients within 60 seconds or less! …and you’re certainly welcome to do more! In our newly designed approach to a one of the biggest issues in patient care, PillTalk provides a simplified approach to patient medica

tion counseling! We believe in empowering the healthcare community and being long-time partners! You can submit your favorite counseling points or newly approved drugs to the ever-growing PillTalk database. While all submissions are reviewed by the Clinical Counseling team, your input is greatly valued! Patient counseling has proven to improve patient education, adherence, and clinical outcomes! Try it out, one drug and one patient at a time! You will notice the difference! Be the BEST at what you do!

04/05/2018

We are currently working on new version of pilltalk app as well as new website. Stay tune.

New Drug Approvals
06/01/2016

New Drug Approvals

Jentadueto XR (linagliptin and metformin hydrochloride extended-release) is used to treat type 2 diabetes. Includes Jentadueto XR side effects,...

Pharma News
05/11/2016

Pharma News

The U.S. Food and Drug Administration is reminding health care professionals and patients not to use drugs intended to be sterile that were...

Pharma News
05/11/2016

Pharma News

Today, the U.S. Food and Drug Administration finalized a rule extending its authority to all to***co products, including e-cigarettes, ci**rs,...

Pharma News
05/03/2016

Pharma News

The U.S. Food and Drug Administration today announced the launch of a historic public education campaign aimed at preventing and reducing to***co...

New Drug Approvals
05/02/2016

New Drug Approvals

Gadavist (gadobutrol) is used to detect supra-aortic or renal artery disease. Includes Gadavist side effects, interactions and indications.

Pharma News
05/01/2016

Pharma News

The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses in...

Pharma News
05/01/2016

Pharma News

First-Time Generic Approved for Statin Crestor High cholesterol, high low-density lipoprotein (LDL) or bad cholesterol , and triglycerides increase...

New Drug Approvals
04/30/2016

New Drug Approvals

ProAir RespiClick (albuterol) is used to treat asthma. Includes ProAir RespiClick side effects, interactions and indications.

New Drug Approvals
04/30/2016

New Drug Approvals

Nuplazid (pimavanserin) is used to treat Parkinson’s disease psychosis. Includes Nuplazid side effects, interactions and indications.

New Drug Approvals
04/27/2016

New Drug Approvals

Xtampza ER (oxycodone) is used to treat severe pain. Includes Xtampza ER side effects, interactions and indications.

Pharma News
04/27/2016

Pharma News

April 22, 2016 - The U.S. Food and Drug Administration today announced a proposal to ban electrical stimulation devices (ESDs) used for...

Pharma News
04/27/2016

Pharma News

The U.S. Food and Drug Administration announced today it is expanding its award-winning The Real Cost campaign to educate rural, white male...

Pharma News
04/27/2016

Pharma News

The U.S. Food and Drug Administration today approved folic acid fortification of corn masa flour. The approval allows manufacturers to voluntarily...

New Drug Approvals
04/26/2016

New Drug Approvals

Cabometyx (cabozantinib) is used to treat advanced renal cell carcinoma. Includes Cabometyx side effects, interactions and indications.

New Drug Approvals
04/21/2016

New Drug Approvals

Gilotrif (afatinib) is used to treat squamous cell carcinoma of the lung. Includes Gilotrif side effects, interactions and indications.

New Drug Approvals
04/12/2016

New Drug Approvals

Venclexta (venetoclax) is used to treat chronic lymphocytic leukemia with 17p deletion. Includes Venclexta side effects, interactions and indications.

Pharma News
04/12/2016

Pharma News

Today, the U.S. Food and Drug Administration s Center for Veterinary Medicine (CVM) took the first step toward rescinding its approval of the use...

New Drug Approvals
04/11/2016

New Drug Approvals

BromSite (bromfenac ophthalmic solution) is used to prevent pain and treat inflammation in patients undergoing cataract surgery. Includes BromSite...

New Drug Approvals
04/06/2016

New Drug Approvals

Inflectra (infliximab-dyyb) is a biosimilar used to treat Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis,...

New Drug Approvals
04/05/2016

New Drug Approvals

Descovy (emtricitabine and tenofovir alafenamide) is used to treat HIV infection. Includes Descovy side effects, interactions and indications.

Pharma News
04/01/2016

Pharma News

FDA Approves Teva s Cinqair to Treat Severe Asthma In March, the U.S. Food and Drug Administration (FDA) approved Teva s Cinqair (reslizumab) as an...

New Drug Approvals
03/31/2016

New Drug Approvals

Defitelio (defibrotide sodium) is used to treat hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Includes Defitelio...

Pharma News
03/31/2016

Pharma News

The U.S. Food and Drug Administration today issued a draft guidance intended to support industry in their development of generic versions of...

Pharma News
03/31/2016

Pharma News

The U.S. Food and Drug Administration today announced the availability of an investigational test to screen blood donations for Zika virus. The...

New Drug Approvals
03/24/2016

New Drug Approvals

Cinqair (reslizumab) is used to treat severe asthma. Includes Cinqair side effects, interactions and indications.

New Drug Approvals
03/23/2016

New Drug Approvals

Taltz (ixekizumab) is used to treat plaque psoriasis. Includes Taltz side effects, interactions and indications.

Pharma News
03/23/2016

Pharma News

In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration...

New Drug Approvals
03/22/2016

New Drug Approvals

Anthim (obiltoxaximab) is used to treat and prevent inhalational anthrax. Includes Anthim side effects, interactions and indications.

Address

MN

Alerts

Be the first to know and let us send you an email when PillTalk posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to PillTalk:

Share